Reinhart Partners’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-49,362
| Closed | -$4.44M | – | 77 |
|
|
2025
Q4 | $4.44M | Sell |
49,362
-21,324
| -30% | -$2.02M | 0.13% | 62 |
|
|
2025
Q3 | $6.96M | Sell |
70,686
-3,109
| -4% | -$308K | 0.23% | 60 |
|
|
2025
Q2 | $6.73M | Sell |
73,795
-6,510
| -8% | -$629K | 0.23% | 65 |
|
|
2025
Q1 | $9.09M | Sell |
80,305
-6,450
| -7% | -$690K | 0.33% | 55 |
|
|
2024
Q4 | $9.16M | Buy |
86,755
+22,220
| +34% | +$2.38M | 0.35% | 61 |
|
|
2024
Q3 | $6.97M | Sell |
64,535
-4,075
| -6% | -$445K | 0.26% | 74 |
|
|
2024
Q2 | $7.45M | Sell |
68,610
-4,697
| -6% | -$554K | 0.31% | 73 |
|
|
2024
Q1 | $9.68M | Sell |
73,307
-621
| -0.8% | -$77.6K | 0.39% | 69 |
|
|
2023
Q4 | $9M | Sell |
73,928
-12,512
| -14% | -$1.4M | 0.4% | 69 |
|
|
2023
Q3 | $9.7M | Sell |
86,440
-3,428
| -4% | -$435K | 0.5% | 68 |
|
|
2023
Q2 | $13.1M | Sell |
89,868
-49,476
| -36% | -$6.72M | 0.66% | 62 |
|
|
2023
Q1 | $18M | Sell |
139,344
-10,750
| -7% | -$1.35M | 0.97% | 43 |
|
|
2022
Q4 | $19.1M | Sell |
150,094
-3,596
| -2% | -$417K | 1.04% | 35 |
|
|
2022
Q3 | $16.1M | Sell |
153,690
-9,062
| -6% | -$994K | 0.99% | 41 |
|
|
2022
Q2 | $17.1M | Sell |
162,752
-2,293
| -1% | -$272K | 0.94% | 48 |
|
|
2022
Q1 | $21.1M | Sell |
165,045
-2,456
| -1% | -$296K | 1.02% | 44 |
|
|
2021
Q4 | $20.7M | Buy |
167,501
+26,618
| +19% | +$3.48M | 0.99% | 46 |
|
|
2021
Q3 | $20M | Buy |
140,883
+28,814
| +26% | +$4.24M | 1.02% | 42 |
|
|
2021
Q2 | $17.5M | Buy |
112,069
+5,646
| +5% | +$915K | 0.87% | 57 |
|
|
2021
Q1 | $16.5M | Buy |
106,423
+27
| +0% | +$4.18K | 0.86% | 60 |
|
|
2020
Q4 | $15.9M | Sell |
106,396
-8,784
| -8% | -$1.24M | 0.97% | 55 |
|
|
2020
Q3 | $15.2M | Sell |
115,180
-8,360
| -7% | -$1.09M | 1.14% | 45 |
|
|
2020
Q2 | $14.3M | Sell |
123,540
-32,321
| -21% | -$3.72M | 1.09% | 47 |
|
|
2020
Q1 | $15.3M | Buy |
155,861
+152,444
| +4,461% | +$20M | 1.48% | 26 |
|
|
2019
Q4 | $496K | Sell |
3,417
-2,307
| -40% | -$318K | 0.04% | 75 |
|
|
2019
Q3 | $763K | Sell |
5,724
-927
| -14% | -$120K | 0.07% | 72 |
|
|
2019
Q2 | $760K | Buy |
6,651
+155
| +2% | +$18.2K | 0.07% | 74 |
|
|
2019
Q1 | $805K | Sell |
6,496
-412
| -6% | -$46.8K | 0.08% | 73 |
|
|
2018
Q4 | $696K | Buy |
6,908
+141
| +2% | +$15.9K | 0.07% | 78 |
|
|
2018
Q3 | $864K | Sell |
6,767
-1,113
| -14% | -$132K | 0.08% | 74 |
|
|
2018
Q2 | $853K | Buy |
7,880
+382
| +5% | +$41.6K | 0.08% | 71 |
|
|
2018
Q1 | $794K | Hold |
7,498
| – | – | 0.08% | 70 |
|
|
2017
Q4 | $878K | Sell |
7,498
-62
| -0.8% | -$7.01K | 0.09% | 74 |
|
|
2017
Q3 | $859K | Buy |
7,560
+1,421
| +23% | +$164K | 0.09% | 70 |
|
|
2017
Q2 | $765K | Buy |
6,139
+258
| +4% | +$30.6K | 0.08% | 74 |
|
|
2017
Q1 | $697K | Sell |
5,881
-618
| -10% | -$70K | 0.06% | 79 |
|
|
2016
Q4 | $651K | Buy |
6,499
+2,049
| +46% | +$220K | 0.06% | 80 |
|
|
2016
Q3 | $562K | Sell |
4,450
-1,061
| -19% | -$131K | 0.06% | 76 |
|
|
2016
Q2 | $644K | Sell |
5,511
-7,416
| -57% | -$839K | 0.06% | 77 |
|
|
2016
Q1 | $1.34M | Hold |
12,927
| – | – | 0.14% | 67 |
|
|
2015
Q4 | $1.29M | Hold |
12,927
| – | – | 0.14% | 72 |
|
|
2015
Q3 | $1.18M | Buy |
12,927
+7,870
| +156% | +$789K | 0.12% | 88 |
|
|
2015
Q2 | $536K | Buy |
+5,057
| New | +$560K | 0.05% | 110 |
|
Other funds holding ZBH
VCM
VPM
Reinhart Partners's ZBH Position: Q1 2026 in Review
Reinhart Partners sold out of Zimmer Biomet (ZBH) in Q1 2026, closing a stake of 49,362 shares — an estimated $4.44M sold.
Reinhart Partners first reported a position in ZBH in Q2 2015 and held it in 43 quarters. The position peaked at $21.1M in Q1 2022. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- Reinhart Partners reported no remaining Zimmer Biomet position as of Q1 2026 after selling out during the quarter.
- Reinhart Partners sold 49,362 Zimmer Biomet shares in Q1 2026, an estimated $4.44M.
- Reinhart Partners first reported a position in Zimmer Biomet in Q2 2015 and held it in 43 quarters.
- Reinhart Partners's Zimmer Biomet position peaked at $21.1M in Q1 2022.
- 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on Reinhart Partners's 13F filing for Q1 2026, filed 13 Apr 2026.